Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more...
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e52d965976c1e0c2f8d89ccb548a2577.jpg"/><p>Novo Nordisk just cut the price of i [...]
Novo Nordisk says Wegovy shows greater weight loss than Eli Lilly's ri
A cross-trial comparison shows Novo's oral semaglutide produced 3.2 percentage points more weight loss than Foundayo, with Eli Lilly's drug seeing significantly higher dropout [...]